Evofem Biosciences Inc (EVFM)
0.0154
0.00 (0.00%)
USD |
OTCM |
May 15, 14:42
Evofem Biosciences Gross Profit Margin (Quarterly): 80.29% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 80.29% |
September 30, 2023 | 63.05% |
June 30, 2023 | 6.71% |
March 31, 2023 | 76.31% |
December 31, 2022 | -112.2% |
September 30, 2022 | 73.63% |
June 30, 2022 | 78.70% |
Date | Value |
---|---|
March 31, 2022 | 74.92% |
December 31, 2021 | 50.84% |
September 30, 2021 | 44.22% |
June 30, 2021 | 54.82% |
March 31, 2021 | 54.21% |
December 31, 2020 | 10.12% |
September 30, 2020 | -14.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-112.2%
Minimum
Dec 2022
80.29%
Maximum
Dec 2023
38.69%
Average
54.51%
Median
Gross Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 68.19% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | 297.1% |
Profit Margin (Quarterly) | -43.69% |
Operating Margin (Quarterly) | -69.85% |
Return on Net Operating Assets | 365.7% |